Swiss National Bank
TNGX icon

Swiss National Bank’s Tango Therapeutics TNGX Stock Holding History

Swiss National Bank’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.84M Hold
87,800
– – ﹤0.01% 1893
2025
Q4 		$778K Buy
+87,800
New +$757K ﹤0.01% 2239
2025
Q1 		– Sell
-94,900
Closed -$293K – 2449
2024
Q4 		$293K Buy
94,900
+11,000
+13% +$51.1K ﹤0.01% 2432
2024
Q3 		$646K Hold
83,900
– – ﹤0.01% 2370
2024
Q2 		$720K Buy
83,900
+3,700
+5% +$28.6K ﹤0.01% 2309
2024
Q1 		$637K Hold
80,200
– – ﹤0.01% 2404
2023
Q4 		$794K Sell
80,200
-19,300
-19% -$168K ﹤0.01% 2358
2023
Q3 		$1.12M Sell
99,500
-15,700
-14% -$95.7K ﹤0.01% 2179
2023
Q2 		$382K Buy
115,200
+10,600
+10% +$38.1K ﹤0.01% 2577
2023
Q1 		$413K Sell
104,600
-12,300
-11% -$71.4K ﹤0.01% 2567
2022
Q4 		$848K Buy
116,900
+44,600
+62% +$314K ﹤0.01% 2421
2022
Q3 		$262K Hold
72,300
– – ﹤0.01% 2675
2022
Q2 		$328K Sell
72,300
-20,800
-22% -$126K ﹤0.01% 2704
2022
Q1 		$706K Buy
93,100
+6,400
+7% +$55.5K ﹤0.01% 2525
2021
Q4 		$948K Buy
+86,700
New +$1.04M ﹤0.01% 2501

Other funds holding TNGX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Swiss National Bank's TNGX Position: Q1 2026 in Review

Swiss National Bank held its Tango Therapeutics (TNGX) position steady in Q1 2026 at 87,800 shares worth $1.84M. The position accounts for ﹤0.01% of the portfolio, ranked #1893.

Swiss National Bank first reported a position in TNGX in Q4 2021 and has held it in 15 quarters since. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

  • Swiss National Bank held 87,800 shares of Tango Therapeutics worth $1.84M as of Q1 2026.
  • Swiss National Bank left its Tango Therapeutics share count unchanged in Q1 2026.
  • Tango Therapeutics made up ﹤0.01% of Swiss National Bank's portfolio in Q1 2026, its #1893 holding.
  • Swiss National Bank first reported a position in Tango Therapeutics in Q4 2021 and has held it in 15 quarters since.
  • 194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on Swiss National Bank's 13F filing for Q1 2026, filed 7 May 2026.